Sector Review: Action in the Healthcare Sector on Nov 7th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Gentiva Health Services (NASDAQ:GTIV): The shares closed at $4.18, up $0.58, or 16.11%, on the day. Its market capitalization is $127.94 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases. Get the most recent company news and stock data here >>
  • Inhibitex, Inc. (NASDAQ:INHX): The shares closed at $9.72, up $1.18, or 13.82%, on the day. Its market capitalization is $759.96 million. About the company: Inhibitex Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel antibody-based products. The Company develops products for the prevention and treatment of serious bacterial and fungal infections in the hospital setting. Get the most recent company news and stock data here >>
  • Idenix Pharmaceuticals (NASDAQ:IDIX): The shares closed at $6.29, up $0.64, or 11.33%, on the day. Its market capitalization is $604.80 million. About the company: Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). Get the most recent company news and stock data here >>
  • MELA Sciences, Inc. (NASDAQ:MELA): The shares closed at $5.16, up $0.5, or 10.73%, on the day. Its market capitalization is $130.35 million. About the company: MELA Sciences Inc is a medical device company focused on the design and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company’s product features a device that captures images of suspicious pigmented skin lesions and extracts data. Get the most recent company news and stock data here >>
  • Amedisys, Inc. (NASDAQ:AMED): The shares closed at $10.59, up $0.9, or 9.29%, on the day. Its market capitalization is $318.01 million. About the company: Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States. Get the most recent company news and stock data here >>

Losers (% price change)

  • Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $10.78, down $1.6, or 12.92%, on the day. Its market capitalization is $502.38 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance. Get the most recent company news and stock data here >>
  • Merge Healthcare Inc. (NASDAQ:MRGE): The shares closed at $5.97, down $0.69, or 10.36%, on the day. Its market capitalization is $535.19 million. About the company: Merge Healthcare Inc. provides medical imaging and information management software and services. The Company offers clinical and medical imaging software applications and development tools. Get the most recent company news and stock data here >>
  • Vertex Pharmaceuticals (NASDAQ:VRTX): The shares closed at $33.22, down $3.41, or 9.31%, on the day. Its market capitalization is $6.93 billion. About the company: Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases. Get the most recent company news and stock data here >>
  • Ariad Pharmaceuticals (NASDAQ:ARIA): The shares closed at $11.02, down $0.99, or 8.24%, on the day. Its market capitalization is $1.46 billion. About the company: ARIAD Pharmaceuticals, Inc. discovers, develops, and commercializes small-molecule drugs to treat aggressive cancers. The Company’s first product candidate is an investigational mTOR inhibitor. ARIAD’s second product candidate is an investigational pan BCR-ABL inhibitor for treatment of blood cancers. Get the most recent company news and stock data here >>
  • Array BioPharma Inc. (NASDAQ:ARRY): The shares closed at $2.60, down $0.23, or 8.13%, on the day. Its market capitalization is $148.25 million. About the company: Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies. Get the most recent company news and stock data here >>

Most Actives (dollar volume)

  • Amgen, Inc. (NASDAQ:AMGN): The shares closed at $58.43, up $3.26, or 5.91%, on the day. Its market capitalization is $51.36 billion. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation. Get the most recent company news and stock data here >>
  • Pfizer Inc. (NYSE:PFE): The shares closed at $20.07, up $0.41, or 2.09%, on the day. Its market capitalization is $156.59 billion. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines. Get the most recent company news and stock data here >>
  • Johnson & Johnson (NYSE:JNJ): The shares closed at $64.00, down $0.12, or 0.19%, on the day. Its market capitalization is $175.38 billion. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. Get the most recent company news and stock data here >>
  • Merck & Co., Inc. (NYSE:MRK): The shares closed at $34.32, up $0.3, or 0.88%, on the day. Its market capitalization is $105.73 billion. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis. Get the most recent company news and stock data here >>
  • Abbott Laboratories (NYSE:ABT): The shares closed at $53.63, up $0.3, or 0.56%, on the day. Its market capitalization is $83.48 billion. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet